PharmaLogic develops and manufactures diagnostic and therapeutic radiopharmaceuticals, while operating an integrated radiopharmacy and supply-chain platform. It evolved from a network of radiopharmacies built through strategic acquisitions into a global platform that supports drug development and commercialization. Its infrastructure includes 17 manufacturing sites worldwide and serves sponsors seeking clinical and commercial production.